Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Christopher Mark Scott , MD

Dermatology • Charlottesville, VA

Active NPI 1548393234 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

1000 East High Street, Suite B
Charlottesville, VA 229024848

Call 4342960113 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

1000 East High Street
Suite B

Charlottesville, VA 229024848

Telephone 4342960113
Organization at the Same NPPES Address or Phone
Dermatology Plc Facility NPI 1215018031

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Dermatology Plc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Graduation Year

2003

Medicare patients

1,828 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $396,509 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $270,863 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,943 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$722,677 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $11,545.40 across 12 records.

By nature of payment

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $11,400.00 across 5 records.
  • Food and Beverage: $145.40 across 7 records.

Reporting-company totals

  • Galderma Laboratories, L.P.: $11,511.04 across 11 records.
  • Sanofi and Genzyme US Companies: $34.36 across 1 record.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

23 years (graduated 2003)

CMS Doctors and Clinicians data list 2003 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2007

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Scott has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Scott as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Charlottesville and Virginia

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 80% of clinicians listed under Dermatology in Charlottesville, VA (2024, 25 clinicians with data). Median for this group: 3,623. Middle half: 2,196 to 4,891.

More Medicare Part B services than 75% of clinicians listed under Dermatology in Virginia (2024, 296 clinicians with data). Median for this group: 3,103. Middle half: 1,172 to 5,850.

Medicare-allowed amount

A higher Medicare-allowed amount than 90% of clinicians listed under Dermatology in Charlottesville, VA (2024, 25 clinicians with data). Median for this group: $212,486. Middle half: $111,745 to $309,638.

A higher Medicare-allowed amount than 75% of clinicians listed under Dermatology in Virginia (2024, 296 clinicians with data). Median for this group: $216,272. Middle half: $87,747 to $385,948.

Paid by Medicare

A higher Medicare payment amount than 85% of clinicians listed under Dermatology in Charlottesville, VA (2024, 25 clinicians with data). Median for this group: $155,554. Middle half: $78,343 to $224,488.

A higher Medicare payment amount than 70% of clinicians listed under Dermatology in Virginia (2024, 296 clinicians with data). Median for this group: $154,901. Middle half: $61,348 to $273,107.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Dermatology in Charlottesville, VA (2024, 32 clinicians with data). Median for this group: 511. Middle half: 192 to 808.

More Part D prescriptions than 95% of clinicians listed under Dermatology in Virginia (2024, 316 clinicians with data). Median for this group: 477. Middle half: 195 to 854.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Dermatology in Charlottesville, VA (2024, 32 clinicians with data). Median for this group: $96,891. Middle half: $19,910 to $305,980.

A higher Part D drug cost than 90% of clinicians listed under Dermatology in Virginia (2024, 316 clinicians with data). Median for this group: $72,832. Middle half: $9,391 to $237,157.

44 active clinicians are listed under Dermatology with a practice address in Charlottesville, VA (423 in Virginia).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Charlottesville

6.8% of these 44 clinicians have the CMS telehealth indicator.

65.9% of these 44 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 12 records totaling $11,545.40.

Manufacturer Payment Nature Product Type Amount ($)
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NEMLUVIO General $3,600.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NEMLUVIO General $2,700.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NEMLUVIO General $2,250.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NEMLUVIO General $2,250.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NEMLUVIO General $600.00
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $95.90
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $34.36
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $4.03
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $3.67
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $3.11
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $2.69
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $1.64

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
1,854 1,421 $128.15 $87.64
17003 Destruction of precancer skin growth, 2-14 growths
1,462 393 $36.00 $6.42
17000 Destruction of precancer skin growth, 1 growth
705 602 $140.95 $53.72
17110 Destruction of skin growth, 1-14 growths
428 385 $193.08 $104.67
11102 Biopsy of related skin growth, first growth
255 234 $188.87 $82.43
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
250 250 $191.45 $107.59
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
198 176 $77.33 $54.60
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
106 94 $248.51 $128.00
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
87 75 $300.76 $158.49
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
87 84 $183.52 $123.95
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
52 48 $313.46 $169.19
36415 Insertion of needle into vein for collection of blood sample
50 33 $19.56 $8.65
17271 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
47 42 $280.32 $145.57
11103 Biopsy of related skin growth, each additional growth
37 30 $102.30 $48.31
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
34 18 $7.53 $0.97
69100 Biopsy of ear
31 27 $169.00 $69.75
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
27 26 $191.78 $99.72
86580 Skin test for tuberculosis
27 27 $20.00 $9.91
11200 Removal of skin tag, 1-15 skin tags
26 26 $152.35 $79.18
11104 Punch biopsy, first skin growth
25 25 $247.40 $115.57
11900 Injection into skin growth, 1-7 growths
24 16 $97.00 $41.52
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
19 19 $267.79 $160.96
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
18 17 $302.00 $182.12
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
18 18 $127.00 $69.66
17004 Destruction of precancer skin growth, 15 or more growths
16 14 $372.88 $161.47

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Triamcinolone Acetonide Triamcinolone Acetonide 209 6,498 $2,279.49 146
Ketoconazole Ketoconazole 155 4,983 $2,715.26 75
Clobetasol Propionate Clobetasol Propionate 134 4,340 $7,116.77 78
Gentamicin Sulfate Gentamicin Sulfate 116 3,058 $6,018.69 73
Betamethasone Diprop Augmented Betamethasone/Propylene Glyc 112 3,075 $2,850.21 71
Fluocinonide Fluocinonide 101 2,973 $6,431.99 62
Nystatin Nystatin 92 2,621 $1,782.07 51
Dupixent Pen Dupilumab 62 1,848 $268,315.50 —
Cyproheptadine Hcl Cyproheptadine Hcl 61 2,062 $519.27 29
Selenium Sulfide Selenium Sulfide 60 1,905 $566.70 30
Mupirocin Mupirocin 51 999 $385.13 35
Cefadroxil Cefadroxil 51 875 $625.85 33
Valacyclovir Valacyclovir Hcl 43 662 $473.45 28
Hydrocortisone Hydrocortisone 33 825 $242.26 26
Metronidazole Metronidazole 30 843 $1,549.43 20
Ammonium Lactate Ammonium Lactate 29 1,090 $391.12 17
Levocetirizine Dihydrochloride Levocetirizine Dihydrochloride 27 1,530 $294.41 12
Fluorouracil Fluorouracil 26 766 $1,511.42 23
Tacrolimus Tacrolimus 24 640 $2,267.48 16
Acitretin Acitretin 24 817 $4,181.74 —
Prednisone Prednisone 22 246 $51.58 20
Pimecrolimus Pimecrolimus 22 830 $14,173.07 —
Amoxicillin Amoxicillin 20 789 $305.21 —
Betamethasone Valerate Betamethasone Valerate 20 560 $1,085.85 —
Fluconazole Fluconazole 19 1,051 $168.76 14

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES VA 0101241283

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Virginia Department of Health Professions.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Other Identifier Group Npi
1215018031 (VA)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20070917000393

Enrollment State Jurisdiction

VA

PECOS Control ID

3072607415

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Dermatology Plc

307 -A N Madison Rd, Orange, VA 229601015

Phone: 5406726591

Dermatology Plc

320 Winding River Ln, Charlottesville, VA 229113569

Phone: 4342960113106

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

3 listed
NPI 1235429226

Doctor of Medicine (M.D.)

NPI 1245231547

Doctor of Medicine (M.D.)

NPI 1114066024

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated March 13, 2007.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1548393234
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: March 13, 2007
Last Update: November 23, 2007
Sole Proprietor: No

Other Dermatology Specialists in Charlottesville

All Dermatology Specialists in Charlottesville

Mailing Address

1000 East High Street, Suite B

Charlottesville, VA 229024848

Phone: 4342960113

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.